Ultomiris 300 MG/3 ML vial 3ML
Ended Awarded
- Contract number
- SPE2DR26F9BM8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,146
Award facts
- Contract value 100% obligated
- $20,146.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,146.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ultomiris (pegcetacoplan) 300 mg/3 mL vials on November 13, 2025, with an ultimate completion date of December 5, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate operations as a major healthcare solutions provider.
AmerisourceBergen Drug Corp serves as a critical prime vendor for federal military and veteran healthcare systems, supplying a comprehensive portfolio of pharmaceuticals and medical supplies through the DLA Medical Supply Chain. The company's substantial IDC vehicle enables it to furnish specialty medications, brand-name and generic drugs, vaccines, and medical supplies globally to support military healthcare programs and other federal customers including the Defense Health Agency and U.S. Coast Guard. This delivery order for Ultomiris, a complement inhibitor used in treating certain blood disorders, exemplifies the contractor's role in delivering specialized pharmaceutical products to support federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F9BM8?
SPE2DR26F9BM8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26F9BM8 worth?
The government has obligated $20,146 on SPE2DR26F9BM8.
Is contract SPE2DR26F9BM8 an order under another contract?
Yes. SPE2DR26F9BM8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9BM8 competed?
The extent of competition for SPE2DR26F9BM8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award